title: A fatal drug interaction.
authors.affiliation: Servicio de Dermatología, Hospital Universitario La Paz, Madrid, España. Electronic address: faprado8@gmail.com.
authors.forename: María Fátima
authors.initials: MF
authors.lastname: Albízuri-Prado
authors.affiliation: Servicio de Dermatología, Hospital Universitario La Paz, Madrid, España.
authors.forename: Alba
authors.initials: A
authors.lastname: Sánchez-Orta
authors.affiliation: Servicio de Dermatología, Hospital Universitario La Paz, Madrid, España.
authors.forename: Cristina
authors.initials: C
authors.lastname: Gómez-Fernández
authors.affiliation: Servicio de Dermatología, Hospital Infanta Sofía, San Sebastián de los Reyes, Madrid, España.
authors.forename: Dulce
authors.initials: D
authors.lastname: Arranz Sánchez
authors.affiliation: Servicio de Dermatología, Hospital Universitario La Paz, Madrid, España.
authors.forename: Pedro
authors.initials: P
authors.lastname: Herranz Pinto
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D000998:Antiviral Agents / Q000009:adverse effects*; D001973:Bromodeoxyuridine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000069287:Capecitabine / Q000009:adverse effects*; D004347:Drug Interactions; D017809:Fatal Outcome; D006801:Humans; D008297:Male; D008875:Middle Aged; D010198:Pancytopenia / Q000139:chemically induced* / Q000175:diagnosis
chemical_list: D000964:Antimetabolites, Antineoplastic; D000998:Antiviral Agents; C020235:brivudine; D000069287:Capecitabine; D001973:Bromodeoxyuridine